Profile data is unavailable for this security.
About the company
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
- Revenue in USD (TTM)0.00
- Net income in USD-24.25m
- Incorporated2008
- Employees59.00
- LocationPolyPid Ltd18 Hasivim Street,P.O Box 7126PETAH TIKVA 4917002IsraelISR
- Websitehttps://www.polypid.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GlycoMimetics Inc | 10.00k | -37.28m | 19.30m | 35.00 | -- | 0.6675 | -- | 1,929.65 | -0.5791 | -0.5791 | 0.0002 | 0.4486 | 0.0002 | -- | 0.0581 | 285.71 | -72.29 | -43.60 | -81.84 | -47.82 | -- | -- | -372,767.40 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 19.40m | 49.00 | -- | -- | -- | 265.75 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
Indaptus Therapeutics Inc | 0.00 | -14.98m | 19.72m | 7.00 | -- | 2.11 | -- | -- | -1.78 | -1.78 | 0.00 | 1.10 | 0.00 | -- | -- | 0.00 | -87.86 | -66.55 | -97.46 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
Goldenwell Biotech Inc | 2.34k | -116.90k | 19.80m | -- | -- | 233.71 | -- | 8,461.54 | -0.0012 | -0.0012 | 0.00002 | 0.0009 | 0.0098 | 0.0071 | -- | -- | -49.07 | -- | -52.16 | -- | 47.01 | -- | -4,995.73 | -- | 37.75 | -- | 0.00 | -- | -95.10 | -- | 88.13 | -- | -- | -- |
Cocrystal Pharma Inc | 0.00 | -16.75m | 19.84m | 12.00 | -- | 0.8784 | -- | -- | -1.65 | -1.65 | 0.00 | 2.22 | 0.00 | -- | -- | 0.00 | -52.03 | -50.94 | -56.92 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
Nymox Pharmaceutical Corp | 0.00 | -4.87m | 20.23m | 3.00 | -- | -- | -- | -- | -0.0536 | -0.0536 | 0.00 | -0.0204 | 0.00 | -- | -- | -- | -255.75 | -264.40 | -- | -464.48 | -- | -- | -- | -13,001.67 | -- | -42.44 | -- | -- | -- | -- | 47.55 | -- | -- | -- |
Vincerx Pharma Inc | 0.00 | -40.16m | 20.40m | 42.00 | -- | 1.32 | -- | -- | -1.89 | -1.89 | 0.00 | 0.5242 | 0.00 | -- | -- | 0.00 | -103.63 | -- | -128.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 36.24 | -- | -- | -- |
AIM ImmunoTech Inc | 202.00k | -28.96m | 20.51m | 26.00 | -- | 2.07 | -- | 101.52 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
Lumos Pharma Inc | 1.53m | -37.13m | 20.62m | 33.00 | -- | 1.18 | -- | 13.52 | -4.59 | -4.59 | 0.1886 | 2.15 | 0.0332 | -- | 8.01 | 46,212.12 | -80.89 | -29.78 | -90.15 | -32.32 | -- | -- | -2,434.69 | -2,937.61 | -- | -- | 0.00 | -- | 34.67 | -30.31 | -9.57 | -- | -- | -- |
Polypid Ltd | 0.00 | -24.25m | 20.70m | 59.00 | -- | 2.90 | -- | -- | -12.35 | -12.35 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -84.94 | -76.92 | -120.03 | -89.61 | -- | -- | -- | -- | -- | -28.72 | 0.5498 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
Sol Gel Technologies Ltd | 1.55m | -27.24m | 20.89m | 36.00 | -- | 0.5407 | -- | 13.44 | -1.02 | -1.02 | 0.0574 | 1.39 | 0.0338 | -- | 0.3774 | 43,166.67 | -59.27 | -31.60 | -64.80 | -35.49 | -- | -- | -1,752.77 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
Neurosense Therapeutics Ltd | 0.00 | -11.28m | 20.97m | 16.00 | -- | -- | -- | -- | -0.7625 | -0.7625 | 0.00 | -0.1219 | 0.00 | -- | -- | 0.00 | -207.24 | -- | -395.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.59 | -- | -- | -- |
MEI Pharma Inc | 66.75m | 26.16m | 20.99m | 46.00 | 0.8025 | 0.4113 | 0.7917 | 0.3144 | 3.93 | 3.93 | 10.02 | 7.66 | 0.6498 | -- | 29.15 | 1,451,174.00 | 25.46 | -25.31 | 30.38 | -28.59 | -- | -- | 39.18 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
Cumberland Pharmaceuticals, Inc. | 38.83m | -8.42m | 21.43m | 91.00 | -- | 0.7778 | -- | 0.5519 | -0.596 | -0.596 | 2.72 | 1.94 | 0.4542 | 0.8812 | 3.08 | 426,654.70 | -9.83 | -7.03 | -14.07 | -9.52 | 83.54 | 79.95 | -21.65 | -17.64 | 1.21 | -37.10 | 0.3717 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
Forte Biosciences Inc | 0.00 | -32.14m | 21.90m | 11.00 | -- | 0.7625 | -- | -- | -1.03 | -1.03 | 0.00 | 0.7882 | 0.00 | -- | -- | 0.00 | -93.54 | -72.06 | -104.30 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
Bioxytran Inc | 0.00 | -4.30m | 21.92m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to PolyPid Ltd's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
AIGH Capital Management LLCas of 31 Mar 2024 | 479.25k | 9.99% |
Rosalind Advisors, Inc.as of 31 Mar 2024 | 415.80k | 8.67% |
DAFNA Capital Management LLCas of 31 Mar 2024 | 185.45k | 3.87% |
Yelin Lapidot Mutual Fund Management Ltd.as of 31 Mar 2024 | 11.15k | 0.23% |
Steward Partners Investment Advisory LLCas of 31 Mar 2024 | 7.35k | 0.15% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 732.00 | 0.02% |
Securities America Advisors, Inc.as of 31 Mar 2024 | 467.00 | 0.01% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 146.00 | 0.00% |
BG Fund Management Luxembourg SAas of 31 Dec 2023 | 104.00 | 0.00% |
UBS Securities LLCas of 31 Mar 2024 | 19.00 | 0.00% |
More ▼
Data from 28 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.